Iranian Firm Produces Nano-Based Bioactive Compounds to Treat Cancer, Diabetes
The company uses artificial intelligence to identify bioactive compounds in plants and evaluate their effects on the body. After confirming the performance of these compounds, the active ingredient of the plant is extracted and then converted to nano through nanoemulsion to increase its accessibility and efficiency in cells and optimize its effectiveness,” said Navid Abedpour, the managing director of the company.
“In the algae section, we have extracted astaxanthin from Haematococcus. These algae are grown in laboratory and academic environments, and their active ingredient is extracted using advanced methods and converted into nanoemulsions. These nanoemulsions have diverse therapeutic capabilities,” he added.
“For instance, in addition to its restorative properties, astaxanthin nanoemulsion has been used as a therapeutic supplement in cancer treatment by changing its formulation and has reduced the size of cancerous tumors in several clinical cases,” Abedpour said.
He went on to say that avocado kernel oil, which has been converted into a nanoemulsion with black seed oil and has analgesic properties, is used in the field of pain control, adding, “In the field of anti-diabetes, the active compounds of fenugreek have been converted into nanoforms that can effectively reduce the blood sugar levels of diabetic patients.”
The 16th International Nano Technology Exhibition and the First Exhibition of Advanced Technologies of Iran was inaugurated at the Tehran International Fairground.
Held from November 2 to 5, the Nano Exhibition featured over 150 innovative companies showcasing advancements in nanotechnology. Meanwhile, the Exhibition of Advanced Technologies hosted 80 knowledge-based and technological products, attracting visitors, particularly students, researchers, and investors.
4155/v
